Skip to content
10-K

Annual Report

Apexigen, Inc.

0000950170-23-003749

← back to feed
Filed
Feb 22, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Feb 17, 2023 24.64M sh
Shares Diluted FY 2022 · Dec 31, 2022 19.79M sh
Shares Diluted FY 2022 · Dec 31, 2021 18.03M sh
Capex FY 2022 · Dec 31, 2022 $57K
Capex FY 2022 · Dec 31, 2021 $54K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$30.69M
Operating Cash Flow restated FY 2022 · Dec 31, 2021 −$23.9M
Short Term Investments FY 2022 · Dec 31, 2022 $2M
Short Term Investments FY 2022 · Dec 31, 2021 $12.92M
Cash And Equivalents FY 2022 · Dec 31, 2022 $14.8M
Cash And Equivalents restated FY 2022 · Dec 31, 2021 $23.44M
Stockholders Equity FY 2022 · Dec 31, 2022 $6.38M
Stockholders Equity restated FY 2022 · Dec 31, 2021 $22M
Stockholders Equity restated FY 2022 · Dec 31, 2020 $49.68M
Current Liabilities FY 2022 · Dec 31, 2022 $16.47M
Current Liabilities restated FY 2022 · Dec 31, 2021 $16.95M
Total Liabilities FY 2022 · Dec 31, 2022 $16.48M
Total Liabilities restated FY 2022 · Dec 31, 2021 $17.1M
Current Assets FY 2022 · Dec 31, 2022 $21.19M
Current Assets restated FY 2022 · Dec 31, 2021 $38.04M
Total Assets FY 2022 · Dec 31, 2022 $22.86M
Total Assets restated FY 2022 · Dec 31, 2021 $39.1M
Eps Diluted FY 2022 · Dec 31, 2022 −$1.62
Eps Diluted FY 2022 · Dec 31, 2021 −$1.60
Eps Basic FY 2022 · Dec 31, 2022 −$1.62
Eps Basic FY 2022 · Dec 31, 2021 −$1.60
Sga Expense FY 2022 · Dec 31, 2022 $9.65M
Sga Expense restated FY 2022 · Dec 31, 2021 $7.29M
Rd Expense FY 2022 · Dec 31, 2022 $23.04M
Rd Expense FY 2022 · Dec 31, 2021 $21.66M
Net Income FY 2022 · Dec 31, 2022 −$32.07M
Net Income restated FY 2022 · Dec 31, 2021 −$28.92M
Operating Income FY 2022 · Dec 31, 2022 −$32.69M
Operating Income restated FY 2022 · Dec 31, 2021 −$28.96M